Addressing Barriers to Transplantation Accessibility With Monzr Al Malki, MD, and Richa Thakur, MD

At the conclusion of this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, Monzr Al Malki, MD, an Associate Professor in the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope, sat down with Richa Thakur, a Palliative Care Physician and Hematology/Oncology Fellow at Zucker School of Medicine at Hofstra/Northwell Health, to discuss his oral abstract presentation entitled “Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation.

Listen along to this podcast to hear insights to Dr. Al Malki’s presentation, including:

  • Barriers that inhibit access to transplant, including for patients with diverse ancestry
  • An overview of the National Marrow Donor Program (NMDP) and the Center for International Blood and Marrow Transplant Research® (CIBMTR®) ACCESS trial and how it’s aiming to address these barriers
  • The results of the study presented ASCO
  • How these findings advance the ability to offer more options to patients in need of transplant
  • Next steps and more!

About Dr. Al Malki and Dr. Thakur

Monzr Al Malki, MD, is an Associate Professor in the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope, one of the largest cancer research and treatment organizations in the United States. Dr. Al Malki’s research focuses on mismatched related and unrelated donors as sources of stem cells for transplantation to treat patients with blood cancers without access to matched donors. He is passionate about creating easier access to transplantation in minority populations with refractory blood cancers and has been an active voice and investigator on this topic.

Richa Thakur, MD, is both a Palliative Care Physician and Hematology/Oncology Fellow at Zucker School of Medicine at Hofstra/Northwell Health. She graduated from Washington University in St. Louis with a bachelor’s in chemistry, medical school at Texas A&M, residency in Internal Medicine, and a fellowship Palliative Care at Zucker School of Medicine. Her research interests include improving quality of life in patients diagnosed with hematologic malignancies.

Related Articles

Responses

Your email address will not be published. Required fields are marked *